The recombinant IgG1 antibodies against B. malayi antigen BmSXP. The scFv sequences were previously isolated from a phage display library constructed using RNA of humans infected with B. malayi. The scFv-Fc format combines the antigen-binding specificity of the scFvs with the stability and multiple labeling sites offered by the Fc portion of human IgG1. The antibody aims to produce mAbs for lymphatic filariasis rapid diagnosis.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
There are currently no Customer reviews or questions for VS-0325-FY163. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.